ABOUT US

Overview

Rockland Technimed Limited (RTL) is a theranostic imaging company committed to the early diagnosis and treatment of hypoxic injury through Oxy-17®, its patented metabolic magnetic resonance imaging medium.  RTL has the world’s largest production source of Oxy-17® Gas, an enriched form of naturally available oxygen, in compliance with the cGMP requirement for medical gases, and commercially available in the United States and European Union for more than 20 years.  RTL’s lead preclinical candidate, Oxy-17® Fusion, is the first ready-to-use intravenous formulation of Oxy-17® Gas and is currently in regulatory marketing studies in Germany (European Union) and the United States.  Oxy-17® Fusion will be commercialized in the United States by RTL, and in the European Union with Nukem Isotopes GmbH. 

Management Team

Our management team brings more than 150 years of combined expertise in developing and securing regulatory approvals, and commercializing medical and diagnostic products at leading Fortune 100 companies in the U.S. and across the globe.

Pradeep M. Gupte
Founder, Chairman & CEO
pgupte@oxy-17.com

Pradeep M. Gupte founded Rockland Technimed Ltd. in 1999 and brings 27 years of experience in the biomedical sector.  Formerly, Pradeep served as director of biomedical engineering and assistant hospital director at Westchester Medical Center in Valhalla, NY and held a faculty appointment at New York Medical College as a research associate professor in the department of surgery and anesthesiology.  Pradeep specializes in the development and commercialization of diversified biomedical devices, and has spent over 25 years establishing Rockland Technimed Ltd. as an entity, raising funds, assembling the management team, overseeing the clinical program from discovery to commercialization, and coordinating operations.

Pradeep has authored more than 60 papers and 12 patents, and served on the editorial review board of the Journal of Clinical Engineering and Quest’s Prosthetics & Orthotics newsletter.  In addition, Pradeep was an active contributor to the medical device standards for the American National Standards Institute and a member of the Technical Advisory Group (TAG) for European standards.  Formerly a consultant and voting member of the FDA’s Device Good Manufacturing Practice Advisory Committee, Pradeep is currently a member of the American Heart Association, American Association for the Advancement of Science, New York Academy of Science, and the International Society of Magnetic Resonance in Medicine.  Pradeep holds a B.S. in engineering from Gujarat University in India and a M.S. in biomedical Engineering from Farleigh Dickinson University.  Pradeep completed his thesis in Patient Data Management in Critical Care Decision Making at the Columbia Presbyterian Medical Center of Columbia University.

George E. Heinze
President & COO
gheinze@oxy-17.com

George E. Heinze assumed the role of president and COO in 2002, after serving as a consultant for 5 years.  Prior to joining Rockland Technimed Ltd., George spent 39 years at Johnson and Johnson where he co-founded Janssen Pharmaceutica Inc. and held several senior positions including director of regulatory affairs, vice president of business development, vice president of operations, director of biological assurance, assistant director of quality assurance and most recently, senior director and vice president at the R.W. Johnson Research Institute.  At his most recent position, George was responsible for the approval and introduction of new pharmaceutical products in Europe and the Far East and research project management worldwide.  During his tenure at Johnson & Johnson, George managed all quality assurance laboratories, development and monitoring of all sterilization procedures for drugs and devices, drug device compliance, submissions of INDs, NDAs and PMAAs, and auditing, manufacturing, purchasing, engineering and technical service.

George is an officer and director of the Association of Medical Instrumentation, and an active member of the American Chemical Society, the Parenteral Drug Association, and Sigma XI and Phi Lambda Upsilon Honorary Societies.  Formerly, Mr Heinze served as the chairman of the PMA Device Section GMP Committee and as an industry representative and chairman of FDA’s Device GMP Committee.  George holds county-appointed positions on the Youth Service Commission and the Human Service Advisory Council and is actively involved in several volunteer community service organizations including United Way, Boy Scouts of America and New Jersey Social Ministry.  George holds a B.A. in chemistry from the University of Pennsylvania and a M.S. in chemistry from Rutgers University.

James L. Spearman, MBA
Vice Chairman, Board of Directors

James Spearman joined the Board of Directoes in mid 2016. Prior to joining Rockland Technimed Ltd., Jim spent 28 years in corporate companies in the industrial, chemical and healthcare imaging & service sectors, including more than10 years with GE Healthcare.  He has core competence in growth, operations, general management and quality, having led 17 Kaizen events at GE Healthcare and led successful passage of six ISO13485 audits.  He also brings expertise in executive leadership & development, corporate finance & compliance, intellectual property creation & protection (successfully prosecuted two U.S. patents) and legal.  He’s a current Board Member & CEO of a national private-equity backed diagnostic imaging service company.

Sanjay Mody
Director, Board of Directors
sanmody@oxy-17.com

Sanjay Mody joined the Board of Directors in late 2015 and is a Co-Founder and Director at Ojas Capital. Sanjay brings with him, over 30 years of experience in international finance. Sanjay has worked as a Banker and Asset Manager at Morgan Stanley Dean Witter. Sanjay has also been a partner at Laidlaw Global, one of the oldest Wall Street investment banks.Sanjay is engaged in consulting, fund sourcing, diversification, planning, online operations, senior living, student housing and yield management of liquid asset in Bonds, Stocks and interest arbitrage.

Sanjay's network spans eight cities globally, that allows him a wide reach into those markets for fund raising, marketing, expidency in regulatory processing etc. Sanjay was instrumental in setting up the first of many international sales offices for diamonds jewelry in New York, before expanding his operations in Antwerp (Belgium), Tel-Aviv (Israel), Bangkok, Moscow and Hong Kong.

Robert DeLaPaz, M.D.
Medical Director, Board of Directors
rdelapaz@oxy-17.com

Dr. Robert DeLaPaz joined the Board of Directors in 2002 and is currently a Professor Emeritus of Radiology and Emeritus Director of Neuroradiology at Columbia University - New York Presbyterian Hospital. As the university’s radiology CIO, Robert also directed the department-wide PACS effort while remaining actively involved in magnetic resonance imaging research. Dr. DeLaPaz is widely known for his work in applications of advanced techniques and functional MRI to analyze brain disorders and brain rehabilitation. Prior to joining Columbia & NYPH in 1995 Dr. DeLaPaz did his postgraduate medical training and held professorships in the medical schools at the NIH, Harvard University, UC San Francisco, Stanford University, Cornell University and Memorial Sloan Kettering Cancer Center.

James A. Baldwin, JD
Corporate Counsel & VP Finance
jbaldwin@oxy-17.com

James A. Baldwin assumed the role of corporate counsel in 2012. James was a partner at Fox Rothschild LLP, and previously held positions at Piliero Mazza PLLC and Patton Boggs LLP. James concentrates his experience on mergers and acquisitions, with an emphasis on leveraged buyouts, private equity and venture capital deals. He also has experience in project finance deals; joint ventures; and formation and regulatory compliance of investment funds, including specialty investment companies such as small business investment companies (SBICs).

James has an extensive securities experience focusing on private placements, public offerings and public company reporting under the Securities Exchange Act of 1934, and a U.S. Small Business Administration regulatory practice with a concentration on 8(a), Veteran-owned, MBE, WBE, DBE certification and regulatory issues. James handles cross-border transactions and international project finance transactions and counsels clients on the structure and terms of their relationship with private and government parties involved in project developments in foreign markets, including China, Africa, Europe, Latin America and other emerging markets. His projects have primarily targeted the energy, heavy manufacturing, technology, telecommunications, infrastructure projects and financial service industries.

James was a co-founder of the charitable organization, Friends United for Need (F.U.N.) and provides tutoring and counseling for at-risk teenagers. He serves as a member of the Human Rights Committee for My Own Place, Inc. in Washington, D.C., and is a past board member for the Rock Ethics Board at the Pennsylvania State University. James also taught "Venture Capital and Technology Transactions, and Anatomy of a Deal: Mergers & Acquisitions Transactions" at Georgetown University Law Center for three semesters. James holds a J.D. degree from Georgetown University Law Center and a B.S. degree (Presidential Scholarship, full academic, Honors Program) from Villanova University.


Anil Gupte, MBA
VP Operations & Logistics
agupte@oxy-17.com

Anil Gupte joined Rockland Technimed Ltd. in 2012. Prior to joining Rockland Technimed Ltd., Anil worked as a management consultant since 1977 and spent more than three decades in fiscal planning and management consultancy, and most recently served as Director of Fiscal Operations at Westchester County Health Care Corp for 22 years. During his tenure at the medical center, Anil was responsible for the conversion and implementation of the General Ledger System, Time Keeping System, Budgeting System, Human Resources System, and Hospital Inventory Management System. In addition, Anil oversaw the General Accounting, Budget, Accounts Payable, Payroll and Treasury departments.

Anil also has extensive experience providing management consultancy services to multinational corporations, including national banks, in the areas of Corporate Strategy, Supply Chain Management, Systems Data Conversions and Implementation, Management Audit, Policy and Procedures Development, and Business Viability Studies. In addition, Anil was a visiting faculty member at the L.D. College of Engineering and the Ahmedabad Productivity Council in Gujarat, India. Anil holds a B.S. in Physics and a MBA in marketing/management from Gujarat University in Ahmedabad, Gujarat, India.

Board of Directors

Pradeep M. Gupte
Founder, Chairman & CEO

George E. Heinze
President & COO

James L. Spearman, MBA
Vice Chairman, Board of Directors

Sanjay Mody
Director, Board of Directors

Robert DeLaPaz, M.D.
Medical Director, Board of Directors

Scientific Advisory Board

William G. Bradley, Jr, M.D., Ph.D., F.A.C.R. 

Dr Bradley has joined the Scientific Advisory Board in 2017. He is a Distinguished Professor and Chairman, Emeritus, of the Department of Radiology at University of California San Diego. He received his BS at the California Institute of Technology and his PhD at Princeton University, both in Chemical Engineering. He completed all his medical training (MD, internship, and Diagnostic Radiology residency) at the University of California San Francisco. He has published more than 200 papers, 54 chapters, and 21 textbooks including the first major textbook on MRI: Magnetic Resonance Imaging (Eds. DD Stark and WG Bradley, Mosby, St Louis, 1988) which is now in its third edition in three volumes.

Dr. Bradley is past president of the International Society for Magnetic Resonance in Medicine (ISMRM) (SMRI) 1988-89. He was on the Board of Trustees of the Radiological Society of North America (RSNA) Research and Education Foundation (1995–2001) and served as the Chairman of the Fund Development Committee of that organization from 1996 to 2008. Dr. Bradley was on the Board of Chancellors of the American College of Radiology (ACR), where he chaired the Commission on Neuroradiology and MRI from 1999 to 2005 and served as Vice President 2005-6. He is currently on the Boards of the International Society for Strategic Studies in Radiology (IS3R), the Association of University Radiologists (AUR), the Academy of Radiology Research, the American Board of MR Safety, and chairs the Board of the Academy of Radiology Leadership and Management. He was honored with the Gold Medal of the ISMRM (SMRM) in 1989, that of the RSNA in 2003, the ACR in 2012, and the American Roentgen Ray Society in 2015. He will be receiving the Gold Medal of the AUR in 2017.

John Pile-Spellman, M.D., F.A.C.R. 

Dr. John Pile-Spellman joined the Scientific Advisory Board in 2008. John is recognized as an international leader in interventional neuroradiology, specializing in the diagnosis, management and treatment of cerebral aneurysms, strokes, tumors, vascular malformations and the development of innovative image-based services.  Formerly a vice-chair of research and director of interventional MRI at Columbia University Medical Center, John continues his research activities at Columbia University’s School of Engineering in the biomedical engineering department.  In addition, he has been an attending radiologist and director of academic interventional neuroradiology at New York Presbyterian Hospital. John has been published in more than 150 peer review journals and served as a reviewer of numerous academic publications, including StrokeThe Journal of Cerebral Blood FlowRadiology, and Lancet.  John received his undergraduate degree from the University of South Dakota and his medical degree from Tufts University School of Medicine in Boston, MA.  He completed some neurosurgical training at Tufts New England Medical Center and a residency in Diagnostic Radiology at Massachusetts General Hospital in Boston, MA.  He then completed fellowships in Neuroradiology at Massachusetts General Hospital and in Interventional Neuroradiology at New York University Medical Center.

Nathaniel Reichek, M.D., F.A.C.C., F.A.H.A. 

Dr. Nathaniel Reichek joined the Scientific Advisory Board in 2002 and is currently the director of research at St. Francis Hospital and professor of medicine and biomedical engineering at the State University of New York at Stony Brook.  Nathaniel has pioneered research in echocardiography and cardiac magnetic resonance imaging and is a past president of the Society for Cardiovascular Magnetic Resonance. Nathaniel has chaired peer review activities for the National Institutes of Health, the American Heart Association and the American College of Cardiology and has served on the editorial boards of all the major U.S. cardiology journals.  He has published over 170 original research reports and over 300 abstracts, mainly in the field of cardiac imaging.  Nathaniel received his medical degree from Columbia University, completed his internship and residency at Bronx Municipal Hospital Center and completed his fellowship at Georgetown University Hospital.

Michael E. Moseley, Ph.D.

Dr. Michael E. Moseley joined the Scientific Advisory Board in 2002 and is currently an associate professor of radiology at the Radiological Sciences Laboratory at Stanford University School of Medicine.  Michael was the former president of the International Society of Magnetic Resonance in Medicine (ISMRM) and remains active in guiding MR societies.  Michael serves on four editorial boards and has authored more than 200 publications including Stroke, Radiology, Neurology and Science.  He was the recipient of the ISMRM Gold Medal for Research in 2000 and his primary research interests’ focus on developing MR methods to detect the earliest effects of experimental and clinical cerebral ischemia.  Michael received his medical training at University of California, San Francisco and earned his Ph.D. in biophysical nuclear magnetic resonance from Uppsala University in Sweden.

Ravinder Reddy, Ph.D.

Dr. Ravinder Reddy joined the Scientific Advisory Board in 2005 and is currently a professor of radiology at the University of Pennsylvania and a director of the Center for Magnetic Resonance and Optical Imaging, a NIH-funded research center.  Ravinder’s research interests include novel, multinuclear magnetic resonance imaging and spectroscopic techniques for early diagnosis and quantification of physiological and functional parameters in pathologies such as arthritis, stroke, cancer and Alzheimer’s disease.  Ravinder is the recipient of the prestigious National Merit Scholarship of the Government of India and serves as a member and chairman of the graduate thesis committee for the department of biochemistry and molecular biophysics at the University of Pennsylvania.  Ravinder is an active member in the International Society of Magnetic Resonance Imaging in Medicine and the Osteoarthritis Research Society International, and serves as a referee for the Journal of Magnetic Resonance and Magnetic Resonance in Medicine.  Ravinder holds a B.Sc. in math, physics and chemistry from Osmania University in Hyderabad, India, a M.Sc. in chemistry from Kakatiya University in Warangal, India and a Ph.D. in chemistry from the Indian Institute of Technology in Kanpur, India.

 


ABOUT US
Overview
Management Team
Board of Directors
Scientific Advisory Board


TECHNOLOGY
Introducing OxyFusion®
Theranostics
OxyFusion® Uses
Patient Benefits


PRODUCTS
Oxy Fusion
Oxy Gas
Oxy Water


MEDIA CENTER
Overview
News

Press Releases
Publications & Abstracts


CONTACT US